Insights On Pharmaceutical Production

31. Challenges And Practical Solutions For Switching To Prefilled Syringes For Injectables 9/1/2020

    To achieve the benefits of moving a final product presentation from vials to prefilled syringes, it is important to understand the challenges during this solution as well as practical solutions.

32. Considerations To Purchasing Low Cost Equipment In Cannabis Manufacturing 11/22/2019

    No one can deny that the cannabis industry is one to watch. Anyone looking to compete in the marijuana and CBD manufacturing business will need to secure process and packaging equipment necessary to produce these products on a commercial scale and with the expected quality. Learn how used process and packaging equipment for the marijuana and CBD industry can fill an immediate and growing need for manufacturing equipment.

33. Relying On Third Party Organizations For Strategic Equipment Acquisitions 9/5/2019

    One of the most critical decisions for a pharmaceutical company is the choice to outsource operations, which leads to determining the optimal supplier with which to partner. When choosing an organization, a company must prioritize risk minimization and choose a dependable supplier with a strong track record. A facility is only as strong as the equipment that it runs, and production is only as effective as the equipment operators.

34. Uquifa Services And Capabilities 11/2/2020

    Find out about Uquifa’s service offering and what makes this company uniquely positioned to support customers in the outsourcing of small molecule APIs.

35. QbD For Process Development, Scale-Up Of A Novel ALS Drug Product 8/4/2020

    A stepwise approach to Quality by Design (QbD), which drives consistent quality into manufacturing, became integral to the success of Amylyx's AMX-0035 campaign. 

36. How To Avoid High Potency API Contamination 3/22/2019

    To ensure that employee exposures are kept within accepted limits and protect the environment while containing costs, pharmaceutical companies and their contract partners who manufacture and handle high containment compounds must carefully select equipment, outline processes and procedures, and deploy appropriate containment technologies. Having standards in place for engineering controls is the first line of defense against harm from cross contamination or exposure to the patient, manufacturing employees, or the environment when working with HPAPIs.In this paper learn how to determine exposure potential and select the correct equipment and technology.

37. Standardization Is Key To Building A Successful Global Business Strategy 4/15/2020

    Standardized approaches to biomanufacturing can lower costs, improve outcomes, and alter the landscape of the global pharmaceutical market.

38. Paving The Way For Tomorrow’s Medicines 10/15/2020

    There is a great need for innovative technologies that can improve the success rate for new drug candidates and pave the way for novel therapies to reach the market. Recent advances in nanoparticle engineering technology promise to accomplish precisely this.

39. How The Integration Of CDMO And CRO Services Benefits Everyone 10/16/2019

    The integration of CDMO services with CRO analytical testing enables high-quality biologic products, speed to market, greater flexibility, and no dependence on external service providers.

40. AsepitQuik S Steam-Thru II Combination Connector 12/9/2020

    Product Manager Maria Bollensen introduces the newest addition to the AseptiQuik® product line of sterile connectors, AseptiQuik STC Connectors integrate the AseptiQuik sterile connector and the Steam-Thru II SIP connector, giving manufacturers greater flexibility between hybrid stainless steel and single-use processing equipment.